Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.

Intermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of IPTc with sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) at monthly intervals reduced clinical malaria,...

Full description

Bibliographic Details
Main Authors: Alassane Dicko, Amadou Barry, Mohamed Dicko, Abdoulbaki I Diallo, Intimbeye Tembine, Yahia Dicko, Niawanlou Dara, Youssoufa Sidibe, Gaoussou Santara, Toumani Conaré, Daniel Chandramohan, Simon Cousens, Paul J Milligan, Diadier A Diallo, Ogobara K Doumbo, Brian Greenwood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3155530?pdf=render
_version_ 1818945832904294400
author Alassane Dicko
Amadou Barry
Mohamed Dicko
Abdoulbaki I Diallo
Intimbeye Tembine
Yahia Dicko
Niawanlou Dara
Youssoufa Sidibe
Gaoussou Santara
Toumani Conaré
Daniel Chandramohan
Simon Cousens
Paul J Milligan
Diadier A Diallo
Ogobara K Doumbo
Brian Greenwood
author_facet Alassane Dicko
Amadou Barry
Mohamed Dicko
Abdoulbaki I Diallo
Intimbeye Tembine
Yahia Dicko
Niawanlou Dara
Youssoufa Sidibe
Gaoussou Santara
Toumani Conaré
Daniel Chandramohan
Simon Cousens
Paul J Milligan
Diadier A Diallo
Ogobara K Doumbo
Brian Greenwood
author_sort Alassane Dicko
collection DOAJ
description Intermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of IPTc with sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) at monthly intervals reduced clinical malaria, severe malaria and malaria infection by >80% in children under 5 years of age. Here we report the results of a follow-on study undertaken to establish whether children who had received IPTc would be at increased risk of malaria during the subsequent malaria transmission season.Morbidity from malaria and the prevalence of malaria parasitaemia and anaemia were measured in children who had previously received IPTc with SP and AQ using similar surveillance methods to those employed during the previous intervention period.1396 of 1508 children (93%) who had previously received IPTc and 1406 of 1508 children (93%) who had previously received placebos were followed up during the high malaria transmission season of the year following the intervention. Incidence rates of clinical malaria during the post-intervention transmission season (July-November 2009) were 1.87 (95% CI 1.76-1.99) and 1.73 (95% CI; 1.62-1.85) episodes per child year in the previous intervention and placebo groups respectively; incidence rate ratio (IRR) 1.09 (95% CI 0.99-1.21) (P = 0.08). The prevalence of malaria infection was similar in the two groups, 7.4% versus 7.5%, prevalence ratio (PR) of 0.99 (95% CI 0.73-1.33) (P = 0.95). At the end of post-intervention malaria transmission season, the prevalence of anaemia, defined as a haemoglobin concentration<11g/dL, was similar in the two groups (56.2% versus 55.6%; PR = 1.01 [95% CI 0.91-1.12]) (P = 0.84).IPTc with SP+AQ was not associated with an increase in incidence of malaria episodes, prevalence of malaria infection or anaemia in the subsequent malaria transmission season.ClinicalTrials.gov NCT00738946.
first_indexed 2024-12-20T08:05:23Z
format Article
id doaj.art-5916c572f4014f13af72011097a85e17
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T08:05:23Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5916c572f4014f13af72011097a85e172022-12-21T19:47:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0168e2339010.1371/journal.pone.0023390Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.Alassane DickoAmadou BarryMohamed DickoAbdoulbaki I DialloIntimbeye TembineYahia DickoNiawanlou DaraYoussoufa SidibeGaoussou SantaraToumani ConaréDaniel ChandramohanSimon CousensPaul J MilliganDiadier A DialloOgobara K DoumboBrian GreenwoodIntermittent preventive treatment of malaria in children (IPTc) is a promising strategy for malaria control. A study conducted in Mali in 2008 showed that administration of three courses of IPTc with sulphadoxine-pyrimethamine (SP) and amodiaquine (AQ) at monthly intervals reduced clinical malaria, severe malaria and malaria infection by >80% in children under 5 years of age. Here we report the results of a follow-on study undertaken to establish whether children who had received IPTc would be at increased risk of malaria during the subsequent malaria transmission season.Morbidity from malaria and the prevalence of malaria parasitaemia and anaemia were measured in children who had previously received IPTc with SP and AQ using similar surveillance methods to those employed during the previous intervention period.1396 of 1508 children (93%) who had previously received IPTc and 1406 of 1508 children (93%) who had previously received placebos were followed up during the high malaria transmission season of the year following the intervention. Incidence rates of clinical malaria during the post-intervention transmission season (July-November 2009) were 1.87 (95% CI 1.76-1.99) and 1.73 (95% CI; 1.62-1.85) episodes per child year in the previous intervention and placebo groups respectively; incidence rate ratio (IRR) 1.09 (95% CI 0.99-1.21) (P = 0.08). The prevalence of malaria infection was similar in the two groups, 7.4% versus 7.5%, prevalence ratio (PR) of 0.99 (95% CI 0.73-1.33) (P = 0.95). At the end of post-intervention malaria transmission season, the prevalence of anaemia, defined as a haemoglobin concentration<11g/dL, was similar in the two groups (56.2% versus 55.6%; PR = 1.01 [95% CI 0.91-1.12]) (P = 0.84).IPTc with SP+AQ was not associated with an increase in incidence of malaria episodes, prevalence of malaria infection or anaemia in the subsequent malaria transmission season.ClinicalTrials.gov NCT00738946.http://europepmc.org/articles/PMC3155530?pdf=render
spellingShingle Alassane Dicko
Amadou Barry
Mohamed Dicko
Abdoulbaki I Diallo
Intimbeye Tembine
Yahia Dicko
Niawanlou Dara
Youssoufa Sidibe
Gaoussou Santara
Toumani Conaré
Daniel Chandramohan
Simon Cousens
Paul J Milligan
Diadier A Diallo
Ogobara K Doumbo
Brian Greenwood
Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
PLoS ONE
title Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
title_full Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
title_fullStr Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
title_full_unstemmed Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
title_short Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
title_sort malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in mali a randomized control trial
url http://europepmc.org/articles/PMC3155530?pdf=render
work_keys_str_mv AT alassanedicko malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT amadoubarry malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT mohameddicko malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT abdoulbakiidiallo malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT intimbeyetembine malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT yahiadicko malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT niawanloudara malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT youssoufasidibe malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT gaoussousantara malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT toumaniconare malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT danielchandramohan malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT simoncousens malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT pauljmilligan malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT diadieradiallo malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT ogobarakdoumbo malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial
AT briangreenwood malariamorbidityinchildrenintheyearaftertheyhadreceivedintermittentpreventivetreatmentofmalariainmaliarandomizedcontroltrial